| Tumor mutational burden standardization initiatives: Recommendations for consistent tumor mutational burden assessment in clinical samples to guide immunotherapy treatment decisions |
36 |
| Long noncoding RNA expression profiling in cancer: Challenges and opportunities |
31 |
| A field guide for cancer diagnostics using cell-free DNA: From principles to practice and clinical applications |
31 |
| A novel group of spindle cell tumors defined by S100 and CD34 co-expression shows recurrent fusions involving RAF BRAF, and NTRK1/2 genes |
28 |
| Molecular mechanisms of long noncoding RNAs-mediated cancer metastasis |
23 |
| Liquid biopsies |
19 |
| 13q deletion is linked to an adverse phenotype and poor prognosis in prostate cancer |
18 |
| Role of miRNAs in immune responses and immunotherapy in cancer |
18 |
| The histologic spectrum of soft tissue spindle cell tumors with NTRK3 gene rearrangements |
15 |
| The role of fork stalling and DNA structures in causing chromosome fragility |
14 |
| New drugs creating new challenges in acute myeloid leukemia |
14 |
| Genomic analysis reveals recurrent deletion of JAK-STAT signaling inhibitors HNRNPK and SOCS1 in mycosis fungoides |
12 |
| Telomere length, telomerase reverse transcriptase promoter mutations, and melanoma risk |
12 |
| Comprehensive molecular and clinicopathological analysis of vascular malformations: A study of 319 cases |
11 |
| The role of TP53 in acute myeloid leukemia: Challenges and opportunities |
10 |
| Detecting disease-defining gene fusions in unclassified round cell sarcomas using anchored multiplex PCR/targeted RNA next-generation sequencing-Molecular and clinicopathological characterization of 16 cases |
10 |
| Multiple DICER1-related tumors in a child with a large interstitial 14q32 deletion |
10 |
| S100 and CD34 positive spindle cell tumor with prominent perivascular hyalinization and a novel NCOA4-RET fusion |
9 |
| Dermatofibrosarcoma protuberans with a novel COL6A3-PDGFD fusion gene and apparent predilection for breast |
9 |
| Copy number variant analysis using genome-wide mate-pair sequencing |
9 |
| Novel EPC1 gene fusions in endometrial stromal sarcoma |
9 |
| An update of molecular pathology of bone tumors. Lessons learned from investigating samples by next generation sequencing |
9 |
| Identification of somatic genetic alterations in ovarian clear cell carcinoma with next generation sequencing |
9 |
| Novel recurrent PHF1-TFE3 fusions in ossifying fibromyxoid tumors |
9 |
| Colorectal cancer susceptibility loci as predictive markers of rectal cancer prognosis after surgery |
9 |
| Clonal evolution analysis of paired anaplastic and well-differentiated thyroid carcinomas reveals shared common ancestor |
8 |
| Most gene fusions in cancer are stochastic events |
8 |
| Usefulness of BCOR gene mutation as a prognostic factor in acute myeloid leukemia with intermediate cytogenetic prognosis |
8 |
| CIC-NUTM1 fusion: A case which expands the spectrum of NUT-rearranged epithelioid malignancies |
8 |
| Chromosome territories and the global regulation of the genome |
8 |
| Aneuploidy, TP53 mutation, and amplification of MYC correlate with increased intratumor heterogeneity and poor prognosis of breast cancer patients |
8 |
| The three-dimensional cancer nucleus |
7 |
| Mutations in spliceosome genes and therapeutic opportunities in myeloid malignancies |
7 |
| Sensitivity to asbestos is increased in patients with mesothelioma and pathogenic germline variants in BAP1 or other DNA repair genes |
7 |
| The cell of origin and the leukemia stem cell in acute myeloid leukemia |
7 |
| WWOX, the FRA16D gene: A target of and a contributor to genomic instability |
7 |
| CINSARC signature as a prognostic marker for clinical outcome in sarcomas and beyond |
7 |
| Comprehensive study of three novel cases of TFEB-amplified renal cell carcinoma and review of the literature: Evidence for a specific entity with poor outcome |
7 |
| RNA sequencing identifies a novel USP9X-USP6 promoter swap gene fusion in a primary aneurysmal bone cyst |
7 |
| Characterization of human telomerase reverse transcriptase promoter methylation and transcription factor binding in differentiated thyroid cancer cell lines |
6 |
| Novel TG-FGFR1 and TRIM33-NTRK1 transcript fusions in papillary thyroid carcinoma |
6 |
| GREB1-CTNNB1 fusion transcript detected by RNA-sequencing in a uterine tumor resembling ovarian sex cord tumor (UTROSCT): A novel CTNNB1 rearrangement |
6 |
| Identification and monitoring of atypical PML/RARA fusion transcripts in acute promyelocytic leukemia |
6 |
| New advances in the molecular classification of pediatric mesenchymal tumors |
6 |
| Mutation analysis of adenomas and carcinomas of the colon: Early and late drivers |
6 |
| Gain of FGF4 is a frequent event in KIT/PDGFRA/SDH/RAS-P WT GIST |
6 |
| Promoter hypermethylation inactivate tumor suppressor FAM134B and is associated with poor prognosis in colorectal cancer |
6 |
| A journey with common fragile sites: From S phase to telophase |
6 |
| Nuclear compartmentalization, dynamics, and function of regulatory DNA sequences |
6 |
| Clonal evolution of acute myeloid leukemia from diagnosis to relapse |
6 |
